Clinical Trial Update: Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease [NA]

View source ↗

Summary

This entry reports a completed long-term clinical trial evaluating resveratrol's effects on fat metabolism in obese men with nonalcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Aarhus | Conditions: Obesity, Nonalcoholic Fatty Liver Disease | NA | Status: COMPLETED